InterCure Ltd.

INCR

IL0011063760

Healthcare Facilities & Services

Delayed TEL AVIV STOCK EXCHANGE Other stock markets 09:30:00 2026-03-11 am EDT			5-day change	1st Jan Change
250.00 ^ILa	-0.24%		-6.79%	-22.74%

Mar. 03	InterCure Receives Noncompliance Notice From Nasdaq	MT
Mar. 03	InterCure receives Nasdaq notification regarding minimum bid requirement	RE

InterCure receives Nasdaq notification regarding minimum bid requirement

Published on 03/03/2026 at 05:02 pm EST

Reuters

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about InterCure Ltd.

Mar. 03	InterCure Receives Noncompliance Notice From Nasdaq	MT
Mar. 03	InterCure receives Nasdaq notification regarding minimum bid requirement	RE
Feb. 19	InterCure announces preliminary estimated 2025 revenue of NIS 265 million, positive adjusted EBITDA and cash of NIS 43 million	RE
Dec. 18	InterCure Ltd on Dec 15, became aware that Bazelet Group of Companies has initiated Restructuring proceedings before the Israeli district court	RE
Nov. 03	Cannasoul Analytics Ltd. announced that it expects to receive funding from InterCure Ltd.	CI
Nov. 03	InterCure Ltd. Enters into A Collaboration Agreement with Cannasoul R&D Ltd	CI
25-10-08	InterCure Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-10-08	Intercure reports first half 2025 results with NIS 130 million in revenue and positive operating cash flow	RE
25-10-08	InterCure Ltd H1 2025 revenue NIS 130 million	RE
25-09-19	Sector Update: Health Care Stocks Mixed Late Afternoon	MT
25-09-19	InterCure to Acquire Cannabis Brand Botanico in Two-Phase Deal	MT
25-09-19	Intercure to buy ISHI, gaining access to premium U.S. cannabis tech and brands	RE
25-09-18	InterCure Ltd. agreed to acquire Botanico Ltd. for ILS 25.3 million.	CI
25-05-01	InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-02-12	Intercure Names Announces Board Changes, Effective February 13, 2025	CI

InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

Employees

320

Sector

Healthcare Facilities & Services

More about the company